TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Verto Pharma AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
811
|
1,734
|
1,106 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
349
|
901
|
420 |
EBITDA |
356
|
913
|
428 |
Total assets |
3,985
|
3,980
|
3,260 |
Current assets |
2,301
|
2,138
|
1,396 |
Current liabilities |
829
|
562
|
299 |
Equity capital |
3,002
|
3,223
|
2,783 |
- share capital |
33
|
36
|
37 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
75.3%
|
81.0%
|
85.4% |
Turnover per employee |
811
|
1,734
|
1,106 |
Profit as a percentage of turnover |
43.0%
|
52.0%
|
38.0% |
Return on assets (ROA) |
8.8%
|
22.6%
|
12.9% |
Current ratio |
277.6%
|
380.4%
|
466.9% |
Return on equity (ROE) |
11.6%
|
28.0%
|
15.1% |
Change turnover |
-783
|
649
|
896 |
Change turnover % |
-49%
|
60%
|
427% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.